BioNTech Co-founders Depart to Launch New mRNA Venture

The Turkish co-founders of BioNTech are leaving the company to establish a new enterprise focused on next-generation mRNA technology. This move comes as BioNTech continues to record significant achievements.

10 Mar, 15:53 — 10 Mar, 16:13

Post Share

Why this matters

Ugur Sahin and Özlem Türeci are renowned for their pioneering work in mRNA technology, particularly their role in developing the first widely approved COVID-19 vaccine. Their departure from BioNTech to pursue a new venture signals a potential new direction in mRNA research and development, which could have significant implications for future medical innovations.

Key entitiesUgur Sahin Özlem Türeci BioNTech New mRNA Venture

The Story

What 7 sources agree on, dispute, and miss

What sources agree on

Ugur Sahin and Özlem Türeci, co-founders of BioNTech, are leaving the company
They are launching a new company
The new venture will focus on next-generation mRNA technology

Key claims1 agreed · 3 unverified

Ugur Sahin and Özlem Türeci developed the first COVID-19 vaccine approved in the West.

unverified·DW

BioNTech is currently deep in the red financially.

unverified·die-presse

✓

The new company will focus on next-generation mRNA drugs.

agreed·iefimeridaYahoonaftemporiki

This is the third biotech company founded by the couple.

unverified·der-standard

Where they diverge

BioNTech's current situation

Yahoo

BioNTech is sharpening its oncology focus

die-presse

BioNTech is deep in the red (experiencing financial losses)

Coverage gaps

The co-founders' previous company formations

Reportedder-standard

MissingDWiefimeridaYahoo+3

The co-founders' quote about being 'pioneers once again'

ReportedDW

MissingiefimeridaYahoonaftemporiki+3

The Story

Analyzing sources…

Source Diversity

High (67/100)

7 sources33/33

Spectrum spread— 3/5 buckets covered17/33

Far L

Left4

Left (4)

DWiefimeridaYahooder-standard

Center1

Center (1)

orf

Right2

Right (2)

naftemporikidie-presse

Far R

Geographic diversity— 4 regions17/34

Austria3Greece2Germany1US1

Political spectrum

LeftCenterRight

der-standard

iefimerida

yahoo

orf

naftemporiki

die-presse

Outlet rating This story

SourceOutletiGeneral editorial lean of the outletStoryiHow they covered this specific storyToneFactuality

der-standardcenter-leftcenter-leftneutral—Provides historical context of founders' ventures

iefimeridacenter-leftcenter-leftneutral—Factual reporting on company changes

DWcentercenter-left

Coverage leans: balanced

The coverage is largely factual and reports on the co-founders' departure and new venture without significant political framing, resulting in a balanced overall lean.

Sources

Showing 2 of 7 sources

DWHigh56d ago

BioNTech founders step down to start new venture

Ugur Sahin and Özlem Türeci were instrumental in developing the first COVID-19 vaccine to be approved in the West. Now they say they "are ready to become pioneers once again."

Read full article →

YahooMostly Factual56d ago